This Cancer Drug Is So Effective, The FDA Approved It Immediately
June 11, 2017
A new cancer drug has overwhelmingly helped shrink or eradicate tumors in patients whose cancer had resisted every other form of treatment.
The results, published in the journal Science, are so striking that the Food and Drug Administration already has approved the drug.

Image credit: Merck
The study followed 86 cancer patients with tumors of the pancreas, prostate, uterus or bone. Each patient was given pembrolizumab, which also goes by the brand name Keytruda.
After taking the drug, 66 patients had their tumors shrink substantially and stabilize, instead of continuing to grow. Among them were 18 patients whose tumors vanished and have not returned.
According to the New York Times, this is the first time a drug has been approved for use against tumors that share a particular genetic profile, regardless of where they appear in the body.
Dr. Jack Jacoub, a medical oncologist and director of thoracic oncology at Memorial Care Cancer Institute at Orange Coast Memorial Medical Center, said "The FDA doesn't take these kinds of things lightly. The data was so good, they had to approve it."
Click Here For The Most Popular On Sunny Skyz
Boy With Down Syndrome Nails The Whitney Houston Challenge, And The Crowd Goes Wild
This Typhoon Photo Is Going Viral For Being Beautiful, Haunting, And Deeply Relatable
People Are Sharing The Funniest Company Fails After This Health Insurance Letter Went Viral
‘Heavily Intoxicated’ Raccoon Passes Out In Liquor Store Bathroom After Breaking In
Cat With A Gat: Owner 3D Prints Toy Glock, Hours Later Walks In On This
Lowe’s Staff Refuse To Give Up On Missing Cat, Find Her 85 Miles Away
Boy With Down Syndrome Nails The Whitney Houston Challenge, And The Crowd Goes Wild
White Dog Spotted Living With A Coyote Pack In Nevada Desert
Stranded Mom Faces A Terrifying Breakdown, Then A Father-Son Duo Steps In To Save The Day
Woman’s First Time On A Trampoline Takes A Hilarious Turn
'That Looks Like Me': Boy Surprises Aunt With Portrait At Art Show
